Fed. Circ. Backs Refusal To Block Abbott IPRs Of DexCom IP

By Adam Lidgett · January 3, 2024, 3:33 PM EST

The Federal Circuit has upheld a lower court's denial of DexCom's motion for a preliminary injunction that would have prohibited rival Abbott from proceeding with administrative reviews of DexCom glucose monitor...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Dexcom, Inc. v. Abbott Diabetes Care, Inc.

Case Number

23-1795

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

April 26, 2023